Brief: Ryvu Therapeutics Q3 Net Loss 26.6 Mln Zlotys
07/11/2024 05:46
Nov 7 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS 26.6 MILLION ZLOTYS
* Q3 OPERATING REVENUE 25.0 MILLION ZLOTYS
* Q3 OPERATING LOSS 26.3 MILLION ZLOTYS
Source text: ID:nEM49fbTza
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project